GRAIL

IPO

Multi-cancer early detection

Public · Menlo Park, United States · Founded 2015 · $835.0M raised

Employees
1001–5000
Founded
2015
Business Model
B2B
Website
grail.com
Total Funding
$835.0M
Last Round
$110.0M Corporate RoundJun 2026
Rounds
6
Type
Public

About

GRAIL is a healthcare company focused on multi-cancer early detection (MCED) through its Galleri blood test, leveraging next-generation sequencing, machine learning, and large-scale clinical studies. Headquartered in Menlo Park, it aims to change the cancer trajectory by detecting deadly cancers early when more treatable.

Summary

GRAIL is a Biotech company based in Menlo Park, United States, founded in 2015. It has raised $835.0M in total across 6 rounds, most recently a $110.0M Corporate Round round in Jun 2026. Investors include Samsung C&T Corporation, Illumina Ventures and Samsung Electronics.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundStrategic Equity FinancingJun 2026
$110.0M

Sign up to see all 7 rounds

Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GRAIL on Indexed.vc
<a href="https://indexed.vc/companies/grail"><img src="https://indexed.vc/api/badge/company/grail" alt="GRAIL on Indexed.vc" width="260" height="76" /></a>